10x Genomics, Inc.
Public company- Headquarters
- PLEASANTON, California
- Ticker
- TXG
- CIK
- 0001770787
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
| Notice date | Workers affected | Cumulative |
|---|---|---|
| May 6, 2025 | 88 | 88 |
| May 6, 2025 | 2 | 90 |
| May 6, 2025 | 3 | 93 |
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class III directorAnsuman Satpathy | Nov 2, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
CFO appointed: Mark Van Oene
- Alamar Biosciences, Inc.
President departs: Timothy “Tod” White
- Seer, Inc.
President, Chief Financial Officer and Treasurer departs: David Horn
- AGILENT TECHNOLOGIES, INC.
Chairperson of the Board of Directors departs: Boon Hwee Koh
- Executive appointment
Class III director appointed: Ansuman Satpathy
Ansuman Satpathy was named Class III director of 10x Genomics, Inc., effective October 28, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Nov 2, 2026Role: Class III director
- Executive appointment
Class III director appointed: Joseph Gilliam
Joseph Gilliam was named Class III director of 10x Genomics, Inc., effective October 28, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Nov 2, 2026Role: Class III director
Last verified Nov 8, 2026